Provided by Tiger Trade Technology Pte. Ltd.

BEONE MEDICINES

206.200
-0.800-0.39%
Volume:5.42M
Turnover:1.11B
Market Cap:317.96B
PE:138.33
High:206.200
Open:203.600
Low:201.600
Close:207.000
52wk High:235.600
52wk Low:153.000
Shares:1.54B
HK Float Shares:1.43B
Volume Ratio:1.51
T/O Rate:0.38%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.491
ROE:14.66%
ROA:7.46%
PB:7.83
PE(LYR):138.33
PS:6.61

Loading ...

BEONE MEDICINES: The Capital Group Companies, Inc. Acquires Shares

HK Disclosure
·
Sep 11

BeOne Medicines Shifts to Fully Electronic Distribution of Corporate Communications

Bulletin Express
·
Sep 10

BeOne Medicines 2026 Interim: Revenue Up 32.3% to USD 3.22 Billion, Net Income Surges to USD 464 Million

Bulletin Express
·
Sep 10

BeOne Medicines Issues Reminder on Shift to Electronic Distribution of Shareholder Materials

Bulletin Express
·
Sep 10

BeOne Medicines Opens New Six-Month Offering for 2018 Employee Share Purchase Plan

Bulletin Express
·
Sep 09

Movement Alert|BEONE MEDICINES Falls 3.01% in Regular Trading, Market Still Digesting US Medicaid Drug Pricing Agreement

Market Focus
·
Sep 09

Movement Alert|BEONE MEDICINES Falls 3.07% in Regular Trading, Market Still Digesting US Medicaid Drug Pricing Agreement Impact

Market Focus
·
Sep 08

Movement Alert|BEONE MEDICINES Declines 3.08% in Regular Trading, Trading at HK$214.2

Market Focus
·
Sep 07

UBS Flags Strong H1 Sales for Chinese Biotech Despite Regulatory Headwinds, Eyes Late-Year Catalysts

Stock News
·
Sep 07

Brokerage Adds Tencent and Innovent Bio to Buy List While Maintaining Positive Outlook on Tech and Hardware Sectors

Stock News
·
Sep 04

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

BeiGene Expands Access to Innovative Cancer Therapy Through New U.S. Agreement

Stock News
·
Sep 01

Movement Alert|BEONE MEDICINES Falls 3.39% in Regular Trading, Post-Earnings Selloff Continues as Revenue Growth Deceleration Sparks Profit-Taking

Market Focus
·
Aug 31

Movement Alert|BEONE MEDICINES Falls 4.19% at Open, Post-Earnings Pressure Persists as Revenue Growth Deceleration Triggers Profit-Taking

Market Focus
·
Aug 31

Beone Medicines' First-Half Profit Surges 386% as Core Drug Drives Revenue Past $3.2 Billion

Deep News
·
Aug 26

BeOne Medicines H1 2026: Revenue Climbs 32%, Net Profit Quadruples on BRUKINSA Momentum

Bulletin Express
·
Aug 26

BEONE MEDICINES Reports Strong First-Half Profit Surge of 385.8%

Stock News
·
Aug 26

Movement Alert|BEONE MEDICINES Rises 3.05% in Regular Trading, Q2 Global Revenue Hits $1.7 Billion with 30% YoY Growth

Market Focus
·
Aug 26

Movement Alert|BEONE MEDICINES Declines 3.07% in Regular Trading, Trading at HK$221.0

Market Focus
·
Aug 24

Movement Alert|BEONE MEDICINES Rises 3.58% in Regular Trading, JPMorgan Increases Stake to 9.05% Amid Strong Half-Year Results

Market Focus
·
Aug 20